China Taiping (0966.HK) experienced a sharp afternoon surge, climbing 8.5% to HK$23.24, reaching its highest share price level since July 2018. At the time of writing, the stock was up 7.75%, with a trading volume exceeding HK$300 million.

During the midday break, China Taiping released an announcement projecting that the group's profit attributable to equity shareholders for the year ending December 31, 2025 (the 2025 fiscal year) is expected to increase by approximately 215% to 225% compared to the prior year (the 2024 fiscal year). The profit attributable to shareholders for the 2024 fiscal year was HK$8.432 billion. The company attributed the anticipated profit increase primarily to an improvement in net investment performance compared to 2024, alongside a one-time impact from a new corporate income tax policy introduced by China's national tax authorities for the insurance industry.

A research report from JPMorgan noted that small and mid-cap Chinese insurance stocks outperformed the broader market last year, with an average price increase of about 58%, reflecting growing market optimism regarding emerging life insurance demand and a favorable macroeconomic outlook. However, the bank suggested that recent modest adjustments to profit and dividend expectations only partially reflect the positive macroeconomic factors anticipated for the second half of 2025. Expressing confidence in the underwriting resilience of insurance companies, earnings per share growth, and dividend visibility, JPMorgan maintains its belief that there is substantial upside potential for domestic insurance stocks. The firm upgraded China Taiping (00966.HK) from 'Underweight' directly to 'Overweight,' raising its target price from HK$9.4 to HK$30, citing optimism about the recovery in life insurance sales and potential upward revisions to near-term profit forecasts as catalysts for further share price appreciation.